Fatigue and depression in patients with lymphoma undergoing autologous peripheral blood stem cell transplantation

被引:19
|
作者
El-Banna, MM [1 ]
Berger, AM
Farr, L
Foxall, MJ
Friesth, B
Schreiner, E
机构
[1] Al Zaytoonah Univ, Amman, Jordan
[2] Univ Nebraska, Med Ctr, Coll Nursing, Omaha, NE 68182 USA
[3] Univ Nebraska, Med Ctr, Peggy D Cowdery Patient Care Ctr, Omaha, NE 68182 USA
关键词
D O I
10.1188/04.ONF.937-944
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose/Objectives: To describe the patterns of depression and fatigue, including its dimensions, and the relationship between these two variables in patients with lymphoma undergoing autologous peripheral blood stem cell transplantation (PBSCT). Design: Prospective, descriptive, correlational, repeated measures. Setting: Midwestern university National Cancer Institute-designated clinical cancer center. Sample: 27 patients with lymphoma aged 19-71 undergoing autologous PBSCT. Methods: The revised Piper Fatigue Scale was used to measure fatigue and its dimensions. The Center for Epidemiologic Studies-Depression Scale was used to measure depression on selected days at baseline and during chemotherapy and recovery. Main Research Variables: Fatigue and its four dimensions (behavioral/severity, sensory, cognitive/mood, and affective meaning) and depression. Findings: Total fatigue, fatigue's four dimension scores, and depression scores changed significantly overtime, with the highest scores at day +7 after transplant. Total fatigue and the four dimension scores were highly and positively correlated with depression, with the highest correlation reported between the affective fatigue dimension and depression. Conclusions: The findings support the importance of assessing fatigue and depression in patients undergoing autologous PBSCT at baseline, during chemotherapy, and throughout recovery. Implications for Nursing: Routine clinical assessment with close observation around day +7 after transplant and patient education about the patterns of fatigue and depression will help the healthcare team to intervene at the appropriate time and may help patients to better manage these symptoms.
引用
收藏
页码:937 / 944
页数:8
相关论文
共 50 条
  • [1] Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation
    Massoud, Radwan
    Assi, Rita
    Fares, Elie
    Haffar, Basel
    Charafeddine, Maya
    Kreidieh, Nabila
    Mahfouz, Rami
    Kanj, Souha S.
    El Zakhem, Aline
    Kharfan-Dabaja, Mohamed
    Bazarbachi, Ali
    El Cheikh, Jean
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2017, 95 : 36 - 41
  • [2] Thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantation
    Yoshimura, C
    Nomura, S
    Katsura, K
    Yamaguchi, K
    Fukuhara, S
    [J]. VOX SANGUINIS, 2000, 78 (02) : 106 - 112
  • [3] Level of anxiety and depression in patients undergoing peripheral blood stem cell transplantation
    Karacan, Y.
    Kapucu, S.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S335 - S335
  • [4] Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation
    Frick, E
    Borasio, GD
    Zehentner, H
    Fischer, N
    Bumeder, I
    [J]. PSYCHO-ONCOLOGY, 2004, 13 (02) : 116 - 124
  • [5] Serum thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantation
    C Shimazaki
    T Inaba
    H Uchiyama
    T Sumikuma
    T Kikuta
    H Hirai
    Y Sudo
    N Yamagata
    E Ashihara
    H Goto
    S Murakami
    H Haruyama
    N Fujita
    M Nakagawa
    [J]. Bone Marrow Transplantation, 1997, 19 : 771 - 775
  • [6] Serum thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantation
    Shimazaki, C
    Inaba, T
    Uchiyama, H
    Sumikuma, T
    Kikuta, T
    Hirai, H
    Sudo, Y
    Yamagata, N
    Ashihara, E
    Goto, H
    Murakami, S
    Haruyama, H
    Fujita, N
    Nakagawa, M
    [J]. BONE MARROW TRANSPLANTATION, 1997, 19 (08) : 771 - 775
  • [7] Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation
    Gordan, LN
    Sugrue, MW
    Lynch, JW
    Williams, KD
    Khan, SA
    Wingard, JR
    Moreb, JS
    [J]. LEUKEMIA & LYMPHOMA, 2003, 44 (05) : 815 - 820
  • [8] Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation
    Guikema, JEJ
    Vellenga, E
    Veeneman, JM
    Hovenga, S
    Bakkus, MHC
    Klip, H
    Bos, NA
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (04) : 748 - 754
  • [9] Subclinical alterations in coagulation and fibrinolysis in patients undergoing autologous peripheral blood stem cell transplantation
    Notoya, A
    Sawada, K
    Ieko, M
    Tarumi, T
    Koizumi, K
    Fukada, Y
    Sato, N
    Yasukouchi, T
    Koike, T
    [J]. LEUKEMIA & LYMPHOMA, 1998, 28 (3-4) : 405 - 413
  • [10] Plerixafor in myeloma and lymphoma patients undergoing autologous stem cell transplantation
    Zielinska, P.
    Markiewicz, M.
    Helbig, G.
    Mietla, M. Dzierzak
    Yrcz-Krzemien, S.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S347 - S347